EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis

Kunlin Chen, Ming Yang, Guangjun Li, Wentao Wang iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0317730 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Kunlin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, NHC Key Laboratory of Echinococcosis Prevention and Control, The Science & Technology Department of Sichuan Province Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) has been emerging a predominant reason for liver transplantation (LT). The complexity of comorbidities in this population increases the possibility of poor transplant outcomes. The purpose of this study was to evaluate the differences in survival after transplantation among patients with NASH HCC and those with non-NASH HCC.

Method

We conducted systematic searches of the PubMed, Embase, Web of Science, and Cochrane Library databases. To analyze the data, both fixed and random-effects models were employed to aggregate hazard ratios (HRs) along with 95% confidence intervals (CIs) for recurrence-free survival (RFS) and overall survival (OS) outcomes. This study is registered with PROSPERO as CRD42024578441.

Results

A total of seven studies were included in this study. This study revealed that there was no significant difference in OS between liver transplant recipients with NASH HCC and those with non-NASH HCC. The RFS of NASH HCC patients were significantly longer. The HRs were 0.70 (95% CI: 0.51-0.97, P = 0.03) for RFS and 0.88 (95% CI: 0.72-1.07, P = 0.21) for OS, respectively.

Conclusion

This study indicates that patients with NASH HCC who undergo LT have comparable OS as those with non-NASH HCC, while NASH HCC was associated with increased RFS. However, further research in randomized trials is necessary to verify these results and address potential selection biases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationNon-alcoholic Fatty Liver DiseaseHumans

Autor:innen und Institutionen

  • Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Wentao Wang

Förderung

  • National Natural Science Foundation of China
  • NHC Key Laboratory of Echinococcosis Prevention and Control
  • The Science & Technology Department of Sichuan Province Funding Project
  • Health Commission of the Tibet Autonomous Region

Zitieren

APA

Chen, K., Yang, M., Li, G., & Wang, W. (2025). Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0317730

Vancouver

Chen K, Yang M, Li G, Wang W. Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE. 2025. doi:10.1371/journal.pone.0317730

BibTeX
@article{Chen2025,
  author = {Chen, Kunlin and Yang, Ming and Li, Guangjun and Wang, Wentao},
  title = {Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0317730}
}
Kostenlos starten →